Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/852cffcc-d92e-431e-b4b4-4f2e1fc7d065/

AREC

Arecor Therapeutics plc
Chart
0.64 GBp
Latest Week 2026-07-17
Snapshot 2026-07-19 · 0.7w · Fresh
0.89
OS Score
75.0%
Value
76.0%
Quality
75.0%
Momentum
6/9
F-Score
0.755
QV
Strategy Eligibility
3 of 23 passing
OS Composite
OS 0.890
Trending Value
Quality × Value
QV 0.755
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
💰
High Yield
🚀
Momentum Leaders
12-1 28%
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
75.0%ile
P/B
0.0×
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
25.00000000
/100 — 1=cheapest
VC2 (Trending Value)
26.00000000
/100
VC3 (Buyback)
26.00000000
/100
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
76.0%ile
ROE
0.103
ROA
0.082
Net Margin
0.387
Op Margin
-2.360
GPA
0.156
Current
4.78
F-Score
6/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.043
Accruals
0.374
lower=better
5yr Consist
No
Accruals ratio of 0.374 is elevated — earnings quality may be lower than headline numbers suggest.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
75.0%ile
6M Return
-23.0%
12M Return
29.6%
12-1 Mom
27.6%
Risk-Adj
0.80
Vol 252d
34.5%
Vol 60d
52.2%
↑ Expanding
Max DD 12M
-27.7%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 28% is very strong — a clear uptrend. Near-term vol (52%) is expanding vs long-term (35%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.89
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 76 peers
Sector Value %ile
90.9%
Sector Quality %ile
84.4%
P/B z-score
-0.60
Sector Avg OS
45.9%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
ABDX Abingdon Health Plc 92.0% 77.0% 78.0% 78.0%
AOTI AOTI, Inc. 92.0% 77.0% 79.0% 78.0%
APTA Aptamer Group PLC 90.0% 75.0% 76.0% 76.0%
AGY Allergy Therapeutics plc 90.0% 76.0% 77.0% 77.0%
BSFA BSF Enterprise Plc 87.0% 73.0% 74.0% 74.0%
AVCT Avacta Group Plc 87.0% 73.0% 75.0% 74.0%
BVC BATM Advanced Communications Ltd. 87.0% 73.0% 75.0% 74.0%
CVSG CVS Group plc 82.0% 70.0% 71.0% 71.0%
Factor Interactions
Value + Quality Intersection
Top-tier on both cheapness (75th) and quality (76th) — the O'Shaughnessy sweet spot, historically the strongest long-term combination.
Trending Value Signal
Cheap (75th value) with strong momentum (75th). The market is starting to recognise the value.
Volatility Expanding
60-day vol (52%) significantly exceeds 252-day (35%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
A
100.0% avg (1 factors)
Quality
D
43.1% avg (7 factors)
Momentum
C
47.5% avg (4 factors)
Risk
C
59.1% avg (1 factors)
Deep value territory, but quality is concerning. This is either a turnaround opportunity or a value trap — the F-Score and accruals ratio will be key differentiators.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends7 snapshots
Factor Persistence7 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.890—2
Value %ile0.750—1
Quality %ile0.760—1
Momentum %ile0.750—2
F-Score6.000—0
Confidence0.653—0
Volatility0.345—0
Value Lens2021-07-20 → 2026-07-19
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Book
0.04
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
10.3%
Return on Assets
8.2%
Net Margin
38.7%
Operating Margin
-236.0%
Gross Profit / Assets
Novy-Marx GPA
15.6%
Current Ratio
4.78
Accruals Ratio
(NI-OCF)/Assets — lower=better
0.374
MomentumPrice trend strength over different horizons
6M Return
-23.0%
12M Return
29.6%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
27.6%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.80
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
4.3%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
6
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
25
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
26
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
26
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity